Notice Type
Secondary Legislation
Notice Title

Consent to the Distribution of a New Medicine

Publication Date
30 Jun 2026

Tags

Medicines Act Consent to the distribution of new medicines Health

Notice Number

2026-sl3648
Title
View PDF
File Type and Size
PDF (21 KB)

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine which was referred to the Minister of Health under the provisions of section 24(5) of the Act and is set out in the Schedule hereto:

Schedule

Product: Labixten meltlets double strength
Active Ingredient: Bilastine 20mg
Dosage Form: Orodispersible tablet
New Zealand Sponsor: A. Menarini New Zealand Pty Limited
Manufacturers: Faes Farma S.A, Leioa, Spain
Faes Farma S.A, Derio, Spain


Dated this 30th day of June 2026.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).